AABB

AABB’s Transfusion Safety and Patient Blood Management Subsection recently released a new “PBM Column.” In this edition, Shaughn Nalezinski, MS, MLS(ASCP)SBB, MLS(AMT), provides a comprehensive overview of #PBM in pediatric patients and emphasizes the importance of tailored approaches to optimize care for children requiring blood transfusions. Access this and other complimentary resources in AABB’s PBM toolkit. 👉  https://bit.ly/43KKxJE #Transfusion #TransfusionMedicine #PBM #RBCs

The July issue of AABB News focuses on the evolution of pediatric and neonatal transfusion care. Here’s what’s inside: 🔹 A look at intrauterine transfusion. 🔹 Addressing unique challenges in pediatric apheresis. 🔹 The evolution of cord blood banking with Frances Verter, PhD. 🔹 Expanding the scope of cord blood banking with Joanne Kurtzberg, MD. Log in to your AABB account for access: https://bit.ly/3v5tG7z #AABBNews #Pediatrics #NeonatalTransfusion #CordBloodBanking #Transfusion #Biotherapies 

Ready to meet another #BioPavilion participant? This week, AABB interviews Dan Waxman, MD, vice president and senior medical director at Versiti Blood Center of Indiana, to discuss his career journey, the challenges Versiti faced during the pandemic and goals for the future. Read the interview and make plans to meet the Versiti team at the Biotherapies Pavilion during the 2024 AABB Annual Meeting, taking place Oct. 19-22 in Houston. 🔗 https://bit.ly/46e8ZEl #Biotherapies #CellTherapy #CellularTherapy #AABB24

In response to ongoing shortages of Rho(D) immune globulin (RhIG), a working group of AABB members released Association Bulletin (AB) #24-02 on Monday. The bulletin provides information and resources to inform clinical practice decisions and inventory management strategies during unexpected and/or prolonged shortages RhIG. It also summarizes the typical use of RhIG and provides approaches that facilities may consider during supply shortages. Read the bulletin: https://bit.ly/3W9RRuU Members should note that AB #24-02 does not contain specific recommendations, nor does it create a standard or accreditation requirement. #TransfusionMedicine #RhIG #RhImmuneGlobulin #MaternalMedicine

Join us for an informative mini-symposium on August 15th! Discover the latest advancements in viscoelastic testing and how they can revolutionize bleeding management. This is a must-attend event for anyone in the medical field! Learn from esteemed experts like Dr. Jonathan H. Chow, Dr. Joseph R. Griggs, and Dr. Michael Mazzeffi. They’ll delve into the latest advancements in blood stewardship and bleeding management, highlighting how modern viscoelastic testing systems are overcoming the limitations of traditional methods. Register now 👉 https://lnkd.in/e-hPAZTm Tag someone who should be there 👇 #HealthcareInnovation #BloodManagement #Webinar AABB

The AABB Foundation is pleased to introduce the 2024 early-career scientific research grant recipients. These promising investigators will each receive a grant of up to $100,000 to further a one- or two-year research project in blood banking, transfusion medicine or biotherapies. Learn more about them and their Foundation-supported research. 👉 https://bit.ly/3VkxARL #AABBFoundation #AABBFamily #Bloodbanking #Transfusion #Biotherapies #Research

In a new employee spotlight interview, AABB spoke with Jeff Wren, vice president, biotherapies, about his background and role at AABB. Meet Jeff and learn more about AABB's products and services advancing biotherapies: https://bit.ly/3xRq4HI #AABBFamily #Biotherapies #AdvancedTherapies

Save the date! Join AABB and HemoSonics, an AABB premium corporate partner, for an insightful mini symposium on blood stewardship and optimized bleeding management. 🗓️: Thursday, Aug. 15. 🕑: 2-3 p.m. ET 📍: Online This complimentary program will explore how cartridge-based whole blood viscoelastic testing (VET) systems are transforming acute bleeding management and how optimized VET platforms enable timely hemostasis, conserve blood, reduce costs and improve outcomes. Expert faculty will guide you through the transition to a goal-directed therapeutic (GDT) approach, highlighting clinical outcomes, cost savings, and health care efficiencies. 👉 Register for free: https://bit.ly/3xO28F7 #AABBCorporatePartner #BloodBanking #BleedingManagement

Are you ready for the next AABB Virtual Journal Club discussion? Join us online at 9 p.m. ET on Tuesday, July 16, or 9 a.m. ET on Wednesday, July 17, to discuss institutional policies and practices related to RhIG immunoprophylaxis after RhD-negative patients receive RhD-incompatible red blood cell and platelet transfusions. Read the article and join the discussion using the #AABBjc hashtag: https://bit.ly/3XWCYhZ #BloodBanking #Transfusion #TransfusionMedicine #RedCells #RBCs #Platelets

Regulatory affairs professionals: AABB is now accepting questions for the “Ask the FDA and CMS/CLIA” session at the 2024 AABB Annual Meeting. This popular session provides an opportunity for members to submit questions to FDA and Centers for Medicare & Medicaid Services/CLIA representatives regarding the agencies’ current thinking on policies, regulations, guidance documents and inspection programs relevant to the oversight of blood and biotherapies. Submit your questions via email to regulatory@aabb.org or leave one in the comments below. 👇 The submission deadline is Aug. 2. #AABB24 #RegulatoryAffiars #BloodBanking #TransfusionMedicine #Transfusion #Biotherapies